Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2251 AL 2265

A Novel Plasma Based Biomarker of Alzheimer's Disease

Bradley-Whitman MA, Abner E, Lynn BC, Lovell MA.

J Alzheimers Dis. 2015;47(3):761-71. doi: 10.3233/JAD-150183.

Mirror Image of the Amyloid-β Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease

Catania M, Di Fede G, Tonoli E, Benussi L, Pasquali C, Giaccone G, Maderna E, Ghidoni R, Tagliavini F.

J Alzheimers Dis. 2015;47(4):877-81. doi: 10.3233/JAD-150179.

Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Aβ42 and Tau

Li G, Xiong K, Korff A, Pan C, Quinn JF, Galasko DR, Liu C, Montine TJ, Peskind ER, Zhang J.

J Alzheimers Dis. 2015;47(4):883-7. doi: 10.3233/JAD-150420.

Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting

Weise D, Tiepolt S, Awissus C, Hoffmann KT, Lobsien D, Kaiser T, Barthel H, Sabri O, Gertz HJ.

J Alzheimers Dis. 2015;48(2):425-32. doi: 10.3233/JAD-150229.

Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease

Sarlus H, Eyjolfsdottir H, Eriksdotter M, Oprica M, Schultzberg M.

J Alzheimers Dis. 2015;48(2):495-505. doi: 10.3233/JAD-143147.

The role of cerebrovascular disease when there is concomitant Alzheimer disease

Vemuri P, Knopman DS.

Biochim Biophys Acta. 2016 May;1862(5):952-6. doi: 10.1016/j.bbadis.2015.09.013. Epub 2015 Sep 25.

Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions

Raskin J, Cummings J, Hardy J, Schuh K, Dean RA.

Curr Alzheimer Res. 2015;12(8):712-22. doi: 10.2174/1567205012666150701103107.

Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers

Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR.

PLoS One. 2015 Oct 1;10(10):e0139233. doi: 10.1371/journal.pone.0139233. eCollection 2015.

Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings

Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Mielke MM, Vemuri P, Lowe V, Senjem ML, Gunter JL, Reyes D, Machulda MM, Roberts R, Petersen RC.

Brain. 2015 Dec;138(Pt 12):3747-59. doi: 10.1093/brain/awv283. Epub 2015 Sep 30.

Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications

Jha NK, Jha SK, Kumar D, Kejriwal N, Sharma R, Ambasta RK, Kumar P.

J Alzheimers Dis. 2015;48(4):891-917. doi: 10.3233/JAD-150379.

Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk

Ebbert MTW, Boehme KL, Wadsworth ME, Staley LA; Alzheimer's Disease Neuroimaging Initiative; Alzheimer's Disease Genetics Consortium; Mukherjee S, Crane PK, Ridge PG, Kauwe JSK.

Alzheimers Dement. 2016 Feb;12(2):121-129. doi: 10.1016/j.jalz.2015.08.163. Epub 2015 Oct 9.

Association of CD33 and MS4A cluster variants with Alzheimer's disease in East Asian populations

Mao YF, Guo ZY, Pu JL, Chen YX, Zhang BR.

Neurosci Lett. 2015 Nov 16;609:235-9. doi: 10.1016/j.neulet.2015.10.007. Epub 2015 Oct 9.

Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer's Disease

Liang HC, Russell C, Mitra V, Chung R, Hye A, Bazenet C, Lovestone S, Pike I, Ward M.

J Proteome Res. 2015 Dec 4;14(12):5063-76. doi: 10.1021/acs.jproteome.5b00892. Epub 2015 Nov 4.

Glia-Mediated Retinal Neuroinflammation as a Biomarker in Alzheimer's Disease

Madeira MH, Ambrósio AF, Santiago AR.

Ophthalmic Res. 2015;54(4):204-11. doi: 10.1159/000440887. Epub 2015 Oct 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias